Israeli scientists Developed breakthrough Drug Therapy for ALS

  Researchers at Ben-Gurion University of the Negev (BGU) are developing a new therapy for Amyotrophic Lateral Sclerosis (ALS) using part of an existing FDA-approved drug that restores the central nervous More...

Israeli scientists Highlights Gene That Could Lead to New Therapies for ALS

Researchers from Ben-Gurion University of the Negev (BGU) have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis More...

Merck Serono and Kadimastem Sign MOU on Drug Screening and Discovery for Neurodegenerative Diseases

–  Yossi Ben-Yossef, CEO and Founder of Kadimastem German global pharmaceutical company Merck Serono, and Israeli Kadimastem (TASE:KDST) , a developer of human pluripotent stem cell-based More...